Zidovudină (Romanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zidovudină" in Romanian language version.

refsWebsite

Global rank Romanian rank

33nih.gov

4^th place

27doi.org

2^nd place

3^rd place

17web.archive.org

1^st place

6harvard.edu

18^th place

27^th place

2fda.gov

447^th place

173^rd place

2ebi.ac.uk

5,849^th place

138^th place

2medicinenet.com

3,840^th place

5,508^th place

1cas.org

8,332^nd place

310^th place

1chemspider.com

8,573^rd place

247^th place

1drugbank.com

low place

160^th place

1drugs.com

399^th place

157^th place

1books.google.com

3^rd place

6^th place

1google.ca

838^th place

285^th place

1mshpriceguide.org

low place

1cdc.gov

218^th place

97^th place

1bhiva.org

low place

1ploshubs.org

low place

1cidrz.org

low place

1aidsperspective.net

low place

1semanticscholar.org

11^th place

638^th place

1aidsmap.com

low place

1inchem.org

4,334^th place

3,440^th place

1zenodo.org

621^st place

1,171^st place

1pnas.org

1,293^rd place

731^st place

1aspetjournals.org

6,663^rd place

low place

1nobelprize.org

301^st place

198^th place

1ama-assn.org

3,257^th place

2,330^th place

1latimes.com

22^nd place

127^th place

aidsmap.com

Side Effects. NAM Aidsmap. „Zidovudine (AZT, Retrovir)”. Arhivat din original la 26 decembrie 2011. Accesat în 28 martie 2012.

aidsperspective.net

Transmission of HIV from infants „Transmission of HIV from infants to women who breastfeed them. | Aids Perspective”. Arhivat din original la 3 decembrie 2013. Accesat în 3 august 2012.

ama-assn.org

jama.ama-assn.org

Approval of Zidovudine (AZT) for Acquired Immunodeficiency Syndrome, September 18, 1987, Brook 258 (11): 1517 – JAMA

aspetjournals.org

molpharm.aspetjournals.org

„Intracellular metabolism of CycloSaligenyl 3'-azido-2', 3'-dideoxythymidine monophosphate, a prodrug of 3'-azido-2', 3'-dideoxythymidine (zidovudine)”. Mol Pharmacol. 56 (6): 1354–61. 1 decembrie 1999. doi:10.1124/mol.56.6.1354. PMID 10570065. Arhivat din original la 21 septembrie 2007.

bhiva.org

„UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure (2011)”. Arhivat din original la 8 aprilie 2014. Accesat în 7 aprilie 2014.

books.google.com

Fischer, Janos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 505. ISBN 9783527607495.

cas.org

commonchemistry.cas.org

CAS Common Chemistry, accesat în 9 aprilie 2021

cdc.gov

„Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis” (PDF). MMWR Recomm Rep. 54 (RR-9): 1–17. septembrie 2005. PMID 16195697.

chemspider.com

Zidovudine (în engleză), ChemSpider, accesat în 19 noiembrie 2016

cidrz.org

CIDRZ. Prevention of AIDS Transmission (PMTCT). „Archived copy”. Arhivat din original la 14 februarie 2012. Accesat în 31 martie 2012.

doi.org

De Clercq E (1994). „HIV resistance to reverse-transcriptase inhibitors”. Biochem Pharmacol. 47 (2): 155–69. doi:10.1016/0006-2952(94)90001-9. PMID 7508227.
„AIDS therapies”. Sci Am. 259 (4): 110–9. 1988. Bibcode:1988SciAm.259d.110Y. doi:10.1038/scientificamerican1088-110. PMID 3072667.
„Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group”. N Engl J Med. 331 (18): 1173–80. 1994. doi:10.1056/NEJM199411033311801. PMID 7935654.
Walensky RP; Paltiel AD; Losina E; et al. (iulie 2006). „The survival benefits of AIDS treatment in the United States”. J. Infect. Dis. 194 (1): 11–9. doi:10.1086/505147. PMID 16741877.
Morris, K (1998). „Short course of AZT halves HIV-1 perinatal transmission”. Lancet. 351 (9103): 651. doi:10.1016/S0140-6736(05)78436-1. PMID 9500334.
Crane, Johanna (2010). „Adverse events and placebo effects: African scientists, HIV, and ethics in the 'global health sciences'”. Social Studies of Science. 40 (6): 843–870. doi:10.1177/0306312710371145. PMID 21553555.
Sun, R.; Eriksson, S.; Wang, L. (2010). „Identification and Characterization of Mitochondrial Factors Modulating Thymidine Kinase 2 Activity”. Nucleosides, Nucleotides and Nucleic Acids. 29 (4–6): 382–385. doi:10.1080/15257771003741018. PMID 20544523.
Scruggs, E. R.; Dirks Naylor, A. J. (2008). „Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy”. Pharmacology. 82 (2): 83–88. doi:10.1159/000134943. PMID 18504416.
Fisher, J. W. (1997). „Erythropoietin: physiologic and pharmacologic aspects”. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine. 216 (3): 358–369. doi:10.3181/00379727-216-44183. PMID 9402140.
Fisher, J. W. (2003). „Erythropoietin: physiology and pharmacology update”. Experimental Biology and Medicine (Maywood, N.J.). 228 (1): 1–14. doi:10.1177/153537020322800101. PMID 12524467.
Richman, D. (1990). „Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus”. The American Journal of Medicine. 88 (5B): 8S–10S. doi:10.1016/0002-9343(90)90414-9. PMID 2186629.
Wainberg, M. A.; Brenner, B. G.; Turner, D. (2005). „Changing Patterns in the Selection of Viral Mutations among Patients Receiving Nucleoside and Nucleotide Drug Combinations Directed against Human Immunodeficiency Virus Type 1 Reverse Transcriptase”. Antimicrobial Agents and Chemotherapy. 49 (5): 1671–1678. doi:10.1128/AAC.49.5.1671-1678.2005. PMC 1087622 . PMID 15855480.
„3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro”. Proc Natl Acad Sci USA. 82 (20): 7096–100. 1985. Bibcode:1985PNAS...82.7096M. doi:10.1073/pnas.82.20.7096. PMC 391317 . PMID 2413459.
„Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex”. Lancet. 1 (8481): 575–80. 1986. doi:10.1016/S0140-6736(86)92808-4. PMID 2869302.
„Molecular targets for AIDS therapy”. Science. 249 (4976): 1533–44. 1990. Bibcode:1990Sci...249.1533M. doi:10.1126/science.1699273. PMID 1699273.
Quan, Y; Rong, L; Liang, C; Wainberg, MA (1999). „Reverse Transcriptase Inhibitors Can Selectively Block the Synthesis of Differently Sized Viral DNA Transcripts in Cells Acutely Infected with Human Immunodeficiency Virus Type 1”. Journal of Virology. 73 (8): 6700–6707. doi:10.1128/JVI.73.8.6700-6707.1999. PMC 112754 . PMID 10400767.
„Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase”. Proc Natl Acad Sci USA. 83 (21): 8333–7. 1986. Bibcode:1986PNAS...83.8333F. doi:10.1073/pnas.83.21.8333. PMC 386922 . PMID 2430286.
„Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides”. N Engl J Med. 321 (11): 726–38. 1989. doi:10.1056/NEJM198909143211106. PMID 2671731.
„Effect of nucleoside reverse-transcriptase inhibitors on mitochondrial DNA synthesis in rats and humans”. J Acquir Immune Defic Syndr. 37 (1): 1132–9. 2004. doi:10.1097/01.qai.0000131585.77530.64. PMID 15319672.
„Intracellular metabolism of CycloSaligenyl 3'-azido-2', 3'-dideoxythymidine monophosphate, a prodrug of 3'-azido-2', 3'-dideoxythymidine (zidovudine)”. Mol Pharmacol. 56 (6): 1354–61. 1 decembrie 1999. doi:10.1124/mol.56.6.1354. PMID 10570065. Arhivat din original la 21 septembrie 2007.
„Structure of 3'-azido-3'-deoxythymidine, AZT”. Acta Crystallogr C. 44 (4): 767–9. aprilie 1988. doi:10.1107/S0108270188000368. PMID 3271074.
„Azidothymidine: crystal structure and possible functional role of the azido group”. Proc Natl Acad Sci USA. 84 (23): 8239–8242. 1987. Bibcode:1987PNAS...84.8239C. doi:10.1073/pnas.84.23.8239. PMC 299517 . PMID 2446321.
Weiss, R (1993). „How does HIV cause AIDS?”. Science. 260 (5112): 1273–9. Bibcode:1993Sci...260.1273W. doi:10.1126/science.8493571. PMID 8493571.
Douek, D; Roederer, M; Koup, R (2009). „Emerging Concepts in the Immunopathogenesis of AIDS”. Annu. Rev. Med. 60: 471–84. doi:10.1146/annurev.med.60.041807.123549. PMC 2716400 . PMID 18947296.
Broder, S. (2009). „The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic”. Antiviral Research. 85 (1): 1–2. doi:10.1016/j.antiviral.2009.10.002. PMC 2815149 . PMID 20018391.
„Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex”. Lancet. 1 (8481): 575–80. 1986. doi:10.1016/s0140-6736(86)92808-4. PMID 2869302.
Fischl MA; Richman DD; Grieco MH; Gottlieb MS; Volberding PA; Laskin OL; Leedom JM; Groopman JE; Mildvan D (1987). „The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial”. N Engl J Med. 317 (4): 185–91. doi:10.1056/NEJM198707233170401. PMID 3299089.

drugbank.com

Zidovudine (în engleză), DrugBank, 17 noiembrie 2015

drugs.com

„Zidovudine”. The American Society of Health-System Pharmacists. Arhivat din original la 21 decembrie 2016. Accesat în 28 noiembrie 2016.

ebi.ac.uk

zidovudine (în engleză), ChEBI, accesat în 19 octombrie 2016
ZIDOVUDINE (în engleză), ChEMBL, accesat în 19 noiembrie 2016

fda.gov

zidovudine (în engleză), Global Substance Registration System, accesat în 19 noiembrie 2016
„HIV/AIDS History of Approvals – HIV/AIDS Historical Time Line 2000 – 2010”. U.S. Food and Drug Administration (FDA). 8 august 2014. Arhivat din original la 23 octombrie 2016.

google.ca

books.google.ca

Reeves, Jacqueline D.; Derdeyn, Cynthia A. (2007). Entry Inhibitors in HIV Therapy. Springer Science & Business Media. p. 179. ISBN 9783764377830.

harvard.edu

adsabs.harvard.edu

„AIDS therapies”. Sci Am. 259 (4): 110–9. 1988. Bibcode:1988SciAm.259d.110Y. doi:10.1038/scientificamerican1088-110. PMID 3072667.
„3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro”. Proc Natl Acad Sci USA. 82 (20): 7096–100. 1985. Bibcode:1985PNAS...82.7096M. doi:10.1073/pnas.82.20.7096. PMC 391317 . PMID 2413459.
„Molecular targets for AIDS therapy”. Science. 249 (4976): 1533–44. 1990. Bibcode:1990Sci...249.1533M. doi:10.1126/science.1699273. PMID 1699273.
„Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase”. Proc Natl Acad Sci USA. 83 (21): 8333–7. 1986. Bibcode:1986PNAS...83.8333F. doi:10.1073/pnas.83.21.8333. PMC 386922 . PMID 2430286.
„Azidothymidine: crystal structure and possible functional role of the azido group”. Proc Natl Acad Sci USA. 84 (23): 8239–8242. 1987. Bibcode:1987PNAS...84.8239C. doi:10.1073/pnas.84.23.8239. PMC 299517 . PMID 2446321.
Weiss, R (1993). „How does HIV cause AIDS?”. Science. 260 (5112): 1273–9. Bibcode:1993Sci...260.1273W. doi:10.1126/science.8493571. PMID 8493571.

inchem.org

„Summary of Data Reported and Evaluation”. 2000. Arhivat din original la 4 ianuarie 2012. Accesat în 11 august 2012.

latimes.com

articles.latimes.com

AZT Approved for AIDS Children. Services, From Times Wire (3 mai 1990). „Archived copy”. Los Angeles Times. Arhivat din original la 4 mai 2015. Accesat în 30 martie 2012.

medicinenet.com

„zidovudine, Retrovir”. Medicinenet.com. 12 august 2010. Arhivat din original la 20 decembrie 2010. Accesat în 14 decembrie 2010.
„ZIDOVUDINE (AZT) – ORAL (Retrovir) side effects, medical uses, and drug interactions”. MedicineNet. Arhivat din original la 30 iunie 2005. Accesat în 9 ianuarie 2006.

mshpriceguide.org

„Zidovudine”. International Drug Price Indicator Guide. Arhivat din original la 14 noiembrie 2018. Accesat în 28 noiembrie 2016.

nih.gov

ncbi.nlm.nih.gov

De Clercq E (1994). „HIV resistance to reverse-transcriptase inhibitors”. Biochem Pharmacol. 47 (2): 155–69. doi:10.1016/0006-2952(94)90001-9. PMID 7508227.
„AIDS therapies”. Sci Am. 259 (4): 110–9. 1988. Bibcode:1988SciAm.259d.110Y. doi:10.1038/scientificamerican1088-110. PMID 3072667.
„Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis” (PDF). MMWR Recomm Rep. 54 (RR-9): 1–17. septembrie 2005. PMID 16195697.
„Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group”. N Engl J Med. 331 (18): 1173–80. 1994. doi:10.1056/NEJM199411033311801. PMID 7935654.
Walensky RP; Paltiel AD; Losina E; et al. (iulie 2006). „The survival benefits of AIDS treatment in the United States”. J. Infect. Dis. 194 (1): 11–9. doi:10.1086/505147. PMID 16741877.
Morris, K (1998). „Short course of AZT halves HIV-1 perinatal transmission”. Lancet. 351 (9103): 651. doi:10.1016/S0140-6736(05)78436-1. PMID 9500334.
Crane, Johanna (2010). „Adverse events and placebo effects: African scientists, HIV, and ethics in the 'global health sciences'”. Social Studies of Science. 40 (6): 843–870. doi:10.1177/0306312710371145. PMID 21553555.
Sun, R.; Eriksson, S.; Wang, L. (2010). „Identification and Characterization of Mitochondrial Factors Modulating Thymidine Kinase 2 Activity”. Nucleosides, Nucleotides and Nucleic Acids. 29 (4–6): 382–385. doi:10.1080/15257771003741018. PMID 20544523.
Scruggs, E. R.; Dirks Naylor, A. J. (2008). „Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy”. Pharmacology. 82 (2): 83–88. doi:10.1159/000134943. PMID 18504416.
Fisher, J. W. (1997). „Erythropoietin: physiologic and pharmacologic aspects”. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine. 216 (3): 358–369. doi:10.3181/00379727-216-44183. PMID 9402140.
Fisher, J. W. (2003). „Erythropoietin: physiology and pharmacology update”. Experimental Biology and Medicine (Maywood, N.J.). 228 (1): 1–14. doi:10.1177/153537020322800101. PMID 12524467.
Richman, D. (1990). „Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus”. The American Journal of Medicine. 88 (5B): 8S–10S. doi:10.1016/0002-9343(90)90414-9. PMID 2186629.
Wainberg, M. A.; Brenner, B. G.; Turner, D. (2005). „Changing Patterns in the Selection of Viral Mutations among Patients Receiving Nucleoside and Nucleotide Drug Combinations Directed against Human Immunodeficiency Virus Type 1 Reverse Transcriptase”. Antimicrobial Agents and Chemotherapy. 49 (5): 1671–1678. doi:10.1128/AAC.49.5.1671-1678.2005. PMC 1087622 . PMID 15855480.
„3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro”. Proc Natl Acad Sci USA. 82 (20): 7096–100. 1985. Bibcode:1985PNAS...82.7096M. doi:10.1073/pnas.82.20.7096. PMC 391317 . PMID 2413459.
„Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex”. Lancet. 1 (8481): 575–80. 1986. doi:10.1016/S0140-6736(86)92808-4. PMID 2869302.
„Molecular targets for AIDS therapy”. Science. 249 (4976): 1533–44. 1990. Bibcode:1990Sci...249.1533M. doi:10.1126/science.1699273. PMID 1699273.
Quan, Y; Rong, L; Liang, C; Wainberg, MA (1999). „Reverse Transcriptase Inhibitors Can Selectively Block the Synthesis of Differently Sized Viral DNA Transcripts in Cells Acutely Infected with Human Immunodeficiency Virus Type 1”. Journal of Virology. 73 (8): 6700–6707. doi:10.1128/JVI.73.8.6700-6707.1999. PMC 112754 . PMID 10400767.
„Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase”. Proc Natl Acad Sci USA. 83 (21): 8333–7. 1986. Bibcode:1986PNAS...83.8333F. doi:10.1073/pnas.83.21.8333. PMC 386922 . PMID 2430286.
„Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides”. N Engl J Med. 321 (11): 726–38. 1989. doi:10.1056/NEJM198909143211106. PMID 2671731.
„Effect of nucleoside reverse-transcriptase inhibitors on mitochondrial DNA synthesis in rats and humans”. J Acquir Immune Defic Syndr. 37 (1): 1132–9. 2004. doi:10.1097/01.qai.0000131585.77530.64. PMID 15319672.
„Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase and human DNA polymerases alpha, beta, and gamma by the 5'-triphosphates of carbovir, 3'-azido-3'-deoxythymidine, 2',3'-dideoxyguanosine and 3'-deoxythymidine. A novel RNA template for the evaluation of antiretroviral drugs”. J Biol Chem. 266 (3): 1754–62. 1991. PMID 1703154.
„Intracellular metabolism of CycloSaligenyl 3'-azido-2', 3'-dideoxythymidine monophosphate, a prodrug of 3'-azido-2', 3'-dideoxythymidine (zidovudine)”. Mol Pharmacol. 56 (6): 1354–61. 1 decembrie 1999. doi:10.1124/mol.56.6.1354. PMID 10570065. Arhivat din original la 21 septembrie 2007.
„Structure of 3'-azido-3'-deoxythymidine, AZT”. Acta Crystallogr C. 44 (4): 767–9. aprilie 1988. doi:10.1107/S0108270188000368. PMID 3271074.
„Azidothymidine: crystal structure and possible functional role of the azido group”. Proc Natl Acad Sci USA. 84 (23): 8239–8242. 1987. Bibcode:1987PNAS...84.8239C. doi:10.1073/pnas.84.23.8239. PMC 299517 . PMID 2446321.
Weiss, R (1993). „How does HIV cause AIDS?”. Science. 260 (5112): 1273–9. Bibcode:1993Sci...260.1273W. doi:10.1126/science.8493571. PMID 8493571.
Douek, D; Roederer, M; Koup, R (2009). „Emerging Concepts in the Immunopathogenesis of AIDS”. Annu. Rev. Med. 60: 471–84. doi:10.1146/annurev.med.60.041807.123549. PMC 2716400 . PMID 18947296.
Broder, S. (2009). „The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic”. Antiviral Research. 85 (1): 1–2. doi:10.1016/j.antiviral.2009.10.002. PMC 2815149 . PMID 20018391.
„Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex”. Lancet. 1 (8481): 575–80. 1986. doi:10.1016/s0140-6736(86)92808-4. PMID 2869302.
Fischl MA; Richman DD; Grieco MH; Gottlieb MS; Volberding PA; Laskin OL; Leedom JM; Groopman JE; Mildvan D (1987). „The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial”. N Engl J Med. 317 (4): 185–91. doi:10.1056/NEJM198707233170401. PMID 3299089.

pubchem.ncbi.nlm.nih.gov

„zidovudină”, zidovudine (în engleză), PubChem, accesat în 19 noiembrie 2016
„zidovudină”, zidovudine (în engleză), PubChem, accesat în 19 octombrie 2016

aidsinfo.nih.gov

„Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health” (PDF). Arhivat din original (PDF) la 22 aprilie 2006. Accesat în 29 martie 2006.

cc.nih.gov

NIH Clinical Center's 50th Anniversary. „Archived copy” (PDF). Arhivat din original (PDF) la 19 iunie 2013. Accesat în 18 aprilie 2012.

nobelprize.org

The DNA Provirus Hypothesis Arhivat în 3 ianuarie 2017, la Wayback Machine.

ploshubs.org

clinicaltrials.ploshubs.org

PLOS Hub. Clinical Trials. http://clinicaltrials.ploshubs.org/article/info%3Adoi%2F10.1371%2Fjournal.pctr.0020011 Arhivat în 6 iunie 2013, la Wayback Machine.

pnas.org

Induction of Endogenous Virus and of Thymidline Kinase. „Archived copy” (PDF). Arhivat din original (PDF) la 24 septembrie 2015. Accesat în 29 martie 2012.

semanticscholar.org

„Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group”. N Engl J Med. 331 (18): 1173–80. 1994. doi:10.1056/NEJM199411033311801. PMID 7935654.

web.archive.org

„Zidovudine”. The American Society of Health-System Pharmacists. Arhivat din original la 21 decembrie 2016. Accesat în 28 noiembrie 2016.
„Zidovudine”. International Drug Price Indicator Guide. Arhivat din original la 14 noiembrie 2018. Accesat în 28 noiembrie 2016.
„UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure (2011)”. Arhivat din original la 8 aprilie 2014. Accesat în 7 aprilie 2014.
„Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health” (PDF). Arhivat din original (PDF) la 22 aprilie 2006. Accesat în 29 martie 2006.
PLOS Hub. Clinical Trials. http://clinicaltrials.ploshubs.org/article/info%3Adoi%2F10.1371%2Fjournal.pctr.0020011 Arhivat în 6 iunie 2013, la Wayback Machine.
CIDRZ. Prevention of AIDS Transmission (PMTCT). „Archived copy”. Arhivat din original la 14 februarie 2012. Accesat în 31 martie 2012.
Transmission of HIV from infants „Transmission of HIV from infants to women who breastfeed them. | Aids Perspective”. Arhivat din original la 3 decembrie 2013. Accesat în 3 august 2012.
„zidovudine, Retrovir”. Medicinenet.com. 12 august 2010. Arhivat din original la 20 decembrie 2010. Accesat în 14 decembrie 2010.
„ZIDOVUDINE (AZT) – ORAL (Retrovir) side effects, medical uses, and drug interactions”. MedicineNet. Arhivat din original la 30 iunie 2005. Accesat în 9 ianuarie 2006.
Side Effects. NAM Aidsmap. „Zidovudine (AZT, Retrovir)”. Arhivat din original la 26 decembrie 2011. Accesat în 28 martie 2012.
„Summary of Data Reported and Evaluation”. 2000. Arhivat din original la 4 ianuarie 2012. Accesat în 11 august 2012.
Induction of Endogenous Virus and of Thymidline Kinase. „Archived copy” (PDF). Arhivat din original (PDF) la 24 septembrie 2015. Accesat în 29 martie 2012.
„Intracellular metabolism of CycloSaligenyl 3'-azido-2', 3'-dideoxythymidine monophosphate, a prodrug of 3'-azido-2', 3'-dideoxythymidine (zidovudine)”. Mol Pharmacol. 56 (6): 1354–61. 1 decembrie 1999. doi:10.1124/mol.56.6.1354. PMID 10570065. Arhivat din original la 21 septembrie 2007.
The DNA Provirus Hypothesis Arhivat în 3 ianuarie 2017, la Wayback Machine.
NIH Clinical Center's 50th Anniversary. „Archived copy” (PDF). Arhivat din original (PDF) la 19 iunie 2013. Accesat în 18 aprilie 2012.
AZT Approved for AIDS Children. Services, From Times Wire (3 mai 1990). „Archived copy”. Los Angeles Times. Arhivat din original la 4 mai 2015. Accesat în 30 martie 2012.
„HIV/AIDS History of Approvals – HIV/AIDS Historical Time Line 2000 – 2010”. U.S. Food and Drug Administration (FDA). 8 august 2014. Arhivat din original la 23 octombrie 2016.

zenodo.org

„Molecular targets for AIDS therapy”. Science. 249 (4976): 1533–44. 1990. Bibcode:1990Sci...249.1533M. doi:10.1126/science.1699273. PMID 1699273.